352 related articles for article (PubMed ID: 27357411)
1. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.
Pac M; Bernatowska E
Eur J Pediatr; 2016 Aug; 175(8):1099-105. PubMed ID: 27357411
[TBL] [Abstract][Full Text] [Related]
2. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008.
Gathmann B; Grimbacher B; Beauté J; Dudoit Y; Mahlaoui N; Fischer A; Knerr V; Kindle G;
Clin Exp Immunol; 2009 Sep; 157 Suppl 1(Suppl 1):3-11. PubMed ID: 19630863
[TBL] [Abstract][Full Text] [Related]
3. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
Pac M
Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of primary immunodeficiency disorders in Australia.
Baumgart KW; Britton WJ; Kemp A; French M; Roberton D
J Allergy Clin Immunol; 1997 Sep; 100(3):415-23. PubMed ID: 9314356
[TBL] [Abstract][Full Text] [Related]
5. 7th International Immunoglobulin Conference: Immunodeficiencies.
Schmidt RE; Ochs HD
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):3-4. PubMed ID: 25546741
[TBL] [Abstract][Full Text] [Related]
6. Primary immunodeficiency diseases in Australia and New Zealand.
Kirkpatrick P; Riminton S
J Clin Immunol; 2007 Sep; 27(5):517-24. PubMed ID: 17588141
[TBL] [Abstract][Full Text] [Related]
7. The German National Registry of Primary Immunodeficiencies (2012-2017).
El-Helou SM; Biegner AK; Bode S; Ehl SR; Heeg M; Maccari ME; Ritterbusch H; Speckmann C; Rusch S; Scheible R; Warnatz K; Atschekzei F; Beider R; Ernst D; Gerschmann S; Jablonka A; Mielke G; Schmidt RE; Schürmann G; Sogkas G; Baumann UH; Klemann C; Viemann D; von Bernuth H; Krüger R; Hanitsch LG; Scheibenbogen CM; Wittke K; Albert MH; Eichinger A; Hauck F; Klein C; Rack-Hoch A; Sollinger FM; Avila A; Borte M; Borte S; Fasshauer M; Hauenherm A; Kellner N; Müller AH; Ülzen A; Bader P; Bakhtiar S; Lee JY; Heß U; Schubert R; Wölke S; Zielen S; Ghosh S; Laws HJ; Neubert J; Oommen PT; Hönig M; Schulz A; Steinmann S; Schwarz K; Dückers G; Lamers B; Langemeyer V; Niehues T; Shai S; Graf D; Müglich C; Schmalzing MT; Schwaneck EC; Tony HP; Dirks J; Haase G; Liese JG; Morbach H; Foell D; Hellige A; Wittkowski H; Masjosthusmann K; Mohr M; Geberzahn L; Hedrich CM; Müller C; Rösen-Wolff A; Roesler J; Zimmermann A; Behrends U; Rieber N; Schauer U; Handgretinger R; Holzer U; Henes J; Kanz L; Boesecke C; Rockstroh JK; Schwarze-Zander C; Wasmuth JC; Dilloo D; Hülsmann B; Schönberger S; Schreiber S; Zeuner R; Ankermann T; von Bismarck P; Huppertz HI; Kaiser-Labusch P; Greil J; Jakoby D; Kulozik AE; Metzler M; Naumann-Bartsch N; Sobik B; Graf N; Heine S; Kobbe R; Lehmberg K; Müller I; Herrmann F; Horneff G; Klein A; Peitz J; Schmidt N; Bielack S; Groß-Wieltsch U; Classen CF; Klasen J; Deutz P; Kamitz D; Lassay L; Tenbrock K; Wagner N; Bernbeck B; Brummel B; Lara-Villacanas E; Münstermann E; Schneider DT; Tietsch N; Westkemper M; Weiß M; Kramm C; Kühnle I; Kullmann S; Girschick H; Specker C; Vinnemeier-Laubenthal E; Haenicke H; Schulz C; Schweigerer L; Müller TG; Stiefel M; Belohradsky BH; Soetedjo V; Kindle G; Grimbacher B
Front Immunol; 2019; 10():1272. PubMed ID: 31379802
[No Abstract] [Full Text] [Related]
8. [Educational program for doctors and nurses taking care for primary immunodeficiency patients treated with subcutaneous immunoglobulins].
Lewandowicz-Uszyńska A; Szaflarska A; Pietrucha B; Tarnowska I
Pol Merkur Lekarski; 2011 Jun; 30(180):452-7. PubMed ID: 21751558
[TBL] [Abstract][Full Text] [Related]
9. Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin.
Stonebraker JS; Farrugia A; Gathmann B; ; Orange JS
J Clin Immunol; 2014 Feb; 34(2):233-44. PubMed ID: 24338563
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin Replacement Therapy for Primary Immunodeficiency.
Sriaroon P; Ballow M
Immunol Allergy Clin North Am; 2015 Nov; 35(4):713-30. PubMed ID: 26454315
[TBL] [Abstract][Full Text] [Related]
11. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06.
Eades-Perner AM; Gathmann B; Knerr V; Guzman D; Veit D; Kindle G; Grimbacher B;
Clin Exp Immunol; 2007 Feb; 147(2):306-12. PubMed ID: 17223972
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.
Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N
Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045
[TBL] [Abstract][Full Text] [Related]
13. Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults.
Slade CA; Bosco JJ; Binh Giang T; Kruse E; Stirling RG; Cameron PU; Hore-Lacy F; Sutherland MF; Barnes SL; Holdsworth S; Ojaimi S; Unglik GA; De Luca J; Patel M; McComish J; Spriggs K; Tran Y; Auyeung P; Nicholls K; O'Hehir RE; Hodgkin PD; Douglass JA; Bryant VL; van Zelm MC
Front Immunol; 2018; 9():694. PubMed ID: 29867917
[TBL] [Abstract][Full Text] [Related]
14. Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry.
Hajjar J; Guffey D; Minard CG; Orange JS
J Clin Immunol; 2017 Feb; 37(2):153-165. PubMed ID: 28124237
[TBL] [Abstract][Full Text] [Related]
15. The European internet-based patient and research database for primary immunodeficiencies: update 2011.
Gathmann B; Binder N; Ehl S; Kindle G;
Clin Exp Immunol; 2012 Mar; 167(3):479-91. PubMed ID: 22288591
[TBL] [Abstract][Full Text] [Related]
16. Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.
Gernez Y; Baker MG; Maglione PJ
Transfusion; 2018 Dec; 58 Suppl 3(Suppl 3):3056-3064. PubMed ID: 30536429
[TBL] [Abstract][Full Text] [Related]
17. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?
Abolhassani H; Asgardoon MH; Rezaei N; Hammarstrom L; Aghamohammadi A
Expert Rev Clin Immunol; 2015; 11(11):1229-43. PubMed ID: 26289377
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).
Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J
J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201
[TBL] [Abstract][Full Text] [Related]
19. How effective are the 6 European Society of Immunodeficiency warning signs for primary immunodeficiency disease?
Arslan S; Ucar R; Caliskaner AZ; Reisli I; Guner SN; Sayar EH; Baloglu I
Ann Allergy Asthma Immunol; 2016 Feb; 116(2):151-155.e1. PubMed ID: 26815708
[TBL] [Abstract][Full Text] [Related]
20. Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.
Costa-Carvalho BT; Sullivan KE; Fontes PM; Aimé-Nobre F; Gonzales IGS; Lima ES; Granato C; de Moraes-Pinto MI
J Clin Immunol; 2018 Jul; 38(5):628-634. PubMed ID: 30006913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
